MELISSA SMITH: Open Payments
NPI 1396275160 · MELBOURNE, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$524 in 17 payments from 10 companies in 2025. Trend: 2023 $0 · 2024 $0 · 2025 $524
Food & beverage: $524
| Company | Payments | Amount |
|---|---|---|
| Regeneron Healthcare Solutions, Inc. | 5 | $129 |
| Phathom Pharmaceuticals, Inc. | 1 | $114 |
| ARS Pharmaceuticals Operations, Inc. | 3 | $81 |
| Oyster Point Pharma, Inc. | 2 | $55 |
| GENZYME CORPORATION | 1 | $32 |
| ABBVIE INC. | 1 | $29 |
| Cochlear Americas | 1 | $26 |
| Amgen Inc. | 1 | $25 |
| Bausch & Lomb Americas Inc. | 1 | $17 |
| PFIZER INC. | 1 | $16 |
Products named: DUPIXENT, VOQUEZNA, NEFFY, TYRVAYA, UBRELVY, COCHLEAR NUCLEUS CI632 COCHLEAR IMPLANT WITH SLIM MODIOLAR ELECTRODE, TEZSPIRE, MIEBO.
Industry payments across FL — which companies pay providers there.
